Profile for Sorrento Therapeutics Inc. (SRNE)

$ 2.51 0.00 (0.00%) Volume: 511.7k 4:00 PM EDT 15-Jul-2019
After Hours:  $ 2.49   -0.02 (-0.80%) Volume: 6.98k 5:58 PM EDT 15-Jul-2019
Business Description:
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.
Address: 4955 Directors Place, San Diego, CA, USA, 92121
Telephone: +1 858 203-4100 Website:
Facsimile: +1 858 203-4028 Email: [email protected]
CEO: Henry Ji
Employees: 382 Market Cap: 328.72m
Issue Type: CS
Auditor: Deloitte & Touche LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology, Morningstar US Market Factor Tilt PR USD, Morningstar US Market Factor Tilt TR USD
Industry Classifications
Sector: Healthcare CIK: 850261
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Commercial Physical And Biological Research (8731)